We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GENRUI BIOTECH INC.

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
03 Mar 2021 - 05 Mar 2021
Virtual Venue
06 Mar 2021 - 10 Mar 2021
Virtual Venue

Saliva Test Fast Tracks Heart Attack Diagnosis

By LabMedica International staff writers
Posted on 07 Sep 2020
Print article
Image: A test tube contains saliva that can be tested for the heart attack biomarker cardiac troponin (Photo courtesy of karenfoleyphoto).
Image: A test tube contains saliva that can be tested for the heart attack biomarker cardiac troponin (Photo courtesy of karenfoleyphoto).
Heart attacks need urgent diagnosis, followed by treatment to restore blood flow to blocked arteries. Diagnosis is based on symptoms (such as chest pain), an electrocardiogram (ECG) and a blood test for cardiac troponin, a protein released into the blood when the heart muscle is injured.

A saliva test could fast track heart attack diagnosis, according to a preliminary study. The innovative technique requires patients to spit into a tube and provides results in 10 minutes, compared to at least one hour for the standard blood test and saliva collection is a non-invasive.

Medical scientists at the Soroka University Medical Centre (Be’er Sheva, Israel) examined if cardiac troponin could be detected in the saliva of patients with heart muscle injury. Saliva samples underwent a unique processing procedure to remove highly abundant proteins. The processing procedure is called Saliva High Abundant Proteins Effective Depletion (SHAPED). A total of 32 patients with heart muscle injury (i.e. they had a positive cardiac troponin blood test) and 13 healthy volunteers were requested to provide saliva samples by spitting into a collecting tube. Then, half of each sample was processed, and the other half remained in its natural state. They then tested the processed and unprocessed saliva samples for cardiac troponin.

The investigators compared the results from the saliva samples (processed and unprocessed) with the blood samples. There was strong agreement between the blood findings and the processed saliva, but not saliva in its natural state. Most of the processed saliva samples tested were positive for troponin, compared to just 6% of the unprocessed saliva. Of the 25 patients with myocardial injury whose samples had advanced processing, 21 were confirmed positive for MI by both methods (sensitivity, 84.0%). Among healthy participants, no cardiac troponin was detected in the processed and unprocessed saliva samples.

Roi Westreich, MD, A Cardiologist and lead author of the study, said, “Since no test has been developed for use on saliva, we had to use commercially available tests intended for whole blood, plasma, or serum, and adjust them for saliva examination. This early work shows the presence of cardiac troponin in the saliva of patients with myocardial injury. Further studies are needed to determine how long troponin stays in the saliva after a heart attack. In addition, we need to know how many patients would erroneously be diagnosed with heart attack and how many cases would be missed.” The study was presented at the digital European Society of Cardiology 2020 congress held August 29 to September 1, 2020 via Sophia Antipolis, France.

Related Links:
Soroka University Medical Centre

New
Gold Supplier
Immunoassay Analyzer
RoboBlot™ Non-Heated
Respiratory SARS-CoV-2 Panel
QIAstat-Dx Respiratory SARS-CoV-2 Panel
Nucleic Acid Purification Kit
Maxwell RSC Viral Total Nucleic Acid Purification Kit
SARS-CoV-2 Antibody Test
EliA SARS-CoV-2-Sp1 IgG test

Print article

Channels

Molecular Diagnostics

view channel
Image: Micrograph of a colorectal adenocarcinoma (Photo courtesy of Wikimedia Commons)

Plasma or Urine Liquid Biopsy Tests May Guide Colorectal Cancer Treatment

A recent paper suggested that liquid biopsy examination of blood or urine could aid in evaluating the effectiveness of therapy for colorectal cancers that had begun to metastasize beyond the site of the... Read more

Industry

view channel
Image: Sysmex CN-Series automated blood coagulation analyzer (Photo courtesy of Sysmex Corporation)

Siemens and Sysmex Extend Agreement to Provide One of the Largest Portfolios of Hemostasis Testing Systems and Reagents

Siemens Healthineers (Erlangen, Germany) and Sysmex Corporation (Kobe, Japan) have renewed their long-standing global supply, distributorship, sales and service agreement for a broad portfolio of hemostasis... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.